These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8481222)

  • 1. [Effect of Kava-Special Extract WS 1490 combined with ethyl alcohol on safety-relevant performance parameters].
    Herberg KW
    Blutalkohol; 1993 Mar; 30(2):96-105. PubMed ID: 8481222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
    Sarris J; Laporte E; Scholey A; King R; Pipingas A; Schweitzer I; Stough C
    Traffic Inj Prev; 2013; 14(1):13-7. PubMed ID: 23259514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks].
    Kinzler E; Krömer J; Lehmann E
    Arzneimittelforschung; 1991 Jun; 41(6):584-8. PubMed ID: 1930344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490].
    Warnecke G
    Fortschr Med; 1991 Feb; 109(4):119-22. PubMed ID: 2029982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava treatment in patients with anxiety.
    Geier FP; Konstantinowicz T
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials.
    Heinze HJ; Münthe TF; Steitz J; Matzke M
    Pharmacopsychiatry; 1994 Nov; 27(6):224-30. PubMed ID: 7870743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/hyperactivity disorder.
    Barkley RA; Murphy KR; O'Connell T; Anderson D; Connor DF
    Neuropsychology; 2006 Jan; 20(1):77-87. PubMed ID: 16460224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study on the influence of picumast dihydrochloride on safety-related performance.
    Herberg KW
    Arzneimittelforschung; 1989 Oct; 39(10A):1348-51. PubMed ID: 2576361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidepressives and traffic safety].
    Herberg KW
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():24-8. PubMed ID: 7959523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Test performance with minimal alcoholic intoxication].
    Bartl G; Lager F; Domesle L
    Blutalkohol; 1996 Jan; 33(1):1-16. PubMed ID: 8777031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava).
    Thompson R; Ruch W; Hasenöhrl RU
    Hum Psychopharmacol; 2004 Jun; 19(4):243-50. PubMed ID: 15181652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
    Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers.
    Kuhlmann J; Berger W; Podzuweit H; Schmidt U
    Pharmacopsychiatry; 1999 Nov; 32(6):235-41. PubMed ID: 10599933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ
    Phytother Res; 2008 Dec; 22(12):1629-34. PubMed ID: 18683852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
    Olsson EM; von Schéele B; Panossian AG
    Planta Med; 2009 Feb; 75(2):105-12. PubMed ID: 19016404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the effects of alcohol on driving-related psychomotor skills by chronic exposure to cannabis.
    Wright A; Terry P
    Psychopharmacology (Berl); 2002 Mar; 160(2):213-9. PubMed ID: 11875640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is residual impairment after alcohol an effect of repeated performance?
    Millar K; Finnigan F; Hammersley RH
    Aviat Space Environ Med; 1999 Feb; 70(2):124-30. PubMed ID: 10206930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.